Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.82M Buy
31,960
+1,445
+5% +$189K 0.05% 198
2025
Q4
$4.16M Sell
30,515
-1,180
-4% -$170K 0.05% 198
2025
Q3
$4.67M Sell
31,695
-466
-1% -$64.6K 0.05% 178
2025
Q2
$4.16M Sell
32,161
-1,316
-4% -$159K 0.05% 191
2025
Q1
$4M Buy
33,477
+13,861
+71% +$1.72M 0.05% 194
2024
Q4
$2.28M Sell
19,616
-978
-5% -$124K 0.03% 241
2024
Q3
$2.78M Buy
20,594
+879
+4% +$118K 0.04% 224
2024
Q2
$2.67M Buy
19,715
+865
+5% +$118K 0.04% 217
2024
Q1
$2.44M Buy
18,850
+2,450
+15% +$296K 0.04% 225
2023
Q4
$1.88M Sell
16,400
-71
-0.4% -$7.09K 0.03% 251
2023
Q3
$1.5M Buy
16,471
+20
+0.1% +$2.06K 0.03% 267
2023
Q2
$1.85M Buy
16,451
+1,952
+13% +$206K 0.03% 244
2023
Q1
$1.52M Buy
14,499
+80
+0.6% +$8.36K 0.03% 264
2022
Q4
$1.59M Buy
14,419
+1,185
+9% +$124K 0.03% 271
2022
Q3
$1.16M Buy
13,234
+835
+7% +$75.9K 0.03% 297
2022
Q2
$969K Buy
12,399
+3,575
+41% +$295K 0.02% 333
2022
Q1
$752K Sell
8,824
-545
-6% -$52.2K 0.01% 404
2021
Q4
$1.12M Buy
9,369
+2,483
+36% +$308K 0.02% 330
2021
Q3
$852K Buy
6,886
+960
+16% +$124K 0.02% 366
2021
Q2
$711K Buy
5,926
+510
+9% +$58.2K 0.01% 399
2021
Q1
$569K Buy
5,416
+2,195
+68% +$223K 0.01% 430
2020
Q4
$328K Buy
3,221
+611
+23% +$57.4K 0.01% 492
2020
Q3
$220K Buy
+2,610
New +$203K 0.01% 517

Other funds holding XYL

Fiduciary Trust's XYL Position: Q1 2026 in Review

Fiduciary Trust increased its Xylem (XYL) stake by 4.7% in Q1 2026, buying an estimated $189K and bringing the position to 31,960 shares worth $3.82M. The position accounts for 0.05% of the portfolio, ranked #198.

Fiduciary Trust first reported a position in XYL in Q3 2020 and has held it in 23 quarters since. The position peaked at $4.67M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Fiduciary Trust held 31,960 shares of Xylem worth $3.82M as of Q1 2026.
  • Fiduciary Trust bought 1,445 Xylem shares in Q1 2026, an estimated $189K.
  • Xylem made up 0.05% of Fiduciary Trust's portfolio in Q1 2026, its #198 holding.
  • Fiduciary Trust first reported a position in Xylem in Q3 2020 and has held it in 23 quarters since.
  • Fiduciary Trust's Xylem position peaked at $4.67M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.